ProterixBio logo — Empowering healthcare providers with innovative blood-based...

ProterixBio

Empowering healthcare providers with innovative blood-based biomarker tests for better management of chronic respiratory diseases.

Founded 2002 Private Equity Total: $100.33M Biotechnology, Health Care +1

General Information

Company Name ProterixBio
Founded Year 2002
Industries Biotechnology, Health Care, Pharmaceutical
Funding Stage Private Equity
Social

BounceWatch is an independent company data service, not affiliated with ProterixBio. To contact ProterixBio, visit proterixbio.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does ProterixBio compare?

A PDF of ProterixBio and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting ProterixBio soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About ProterixBio

ProterixBio, established in 2002, specializes in developing unique blood-based biomarker tests aimed at improving the management of chronic respiratory diseases. The company's products empower healthcare providers to manage their patients more effectively by providing real-time, biological assessments of a patient’s disease state, potentially reducing unnecessary hospital admissions. This approach not only aims to enhance patient outcomes but also to lower overall healthcare costs. Located in Billerica, Massachusetts, ProterixBio continues to make strides in the critical fields of biotechnology, healthcare, and pharmaceuticals. The company secured a noteworthy $18.80M Private Equity Round investment on 09 July 2013.

Business keywords: Chronic Respiratory Diseases, Biomarker Tests, Healthcare Management, Real-time Assessment, Patient Outcomes, Healthcare Costs, Proprietary Tests, Medical Innovation, Diagnostic Tools, Disease Management, Biological Assessments, Hospital Admissions, Massachusetts

Funding Rounds & Investors (9)

View All
Funding Stage Amount Investors Lead Investors Date
Private Equity Round $18.80M -
09 Jul 2013
Debt Financing $1.06M -
11 Mar 2013
Debt Financing $3.83M -
21 Feb 2013
Debt Financing $5.26M -
06 Mar 2012
Series D $25.00M 5
New Science Ventures, F2 Ventures +3
14 Jun 2010
Venture Round $20.69M 2
New York Angels, Blackfin Technology
31 Dec 2007
Series C $20.69M 2
F2 Ventures, Blackfin Technology
19 Nov 2007
Series B $3.00M 2
New York Angels, F2 Ventures
18 Feb 2005
Series A $2.00M 1
New York Angels
12 Jan 2004

ProterixBio Alternatives & Competitors

View All Alternatives
ProterixBio vs

Our Mission To create and commercialize innovative blood tests that accurately assess imminent disea...

Debt Financing
20 employees
Biotechnology, Health Care
ProterixBio vs
Aevice Health
Aevice Health Singapore

Every step we take goes a long way towards helping patients breathe better.

Seed
18 employees
Biotechnology, Hardware
ProterixBio vs

Domus is developing affordable and accurate respiratory disease home testing for everyone, everywher...

Grant
5 employees
Biotechnology, Health Care

FAQ About ProterixBio

Empowering healthcare providers with innovative blood-based biomarker tests for better management of chronic respiratory diseases.
ProterixBio was founded in 2002.
ProterixBio operates in Biotechnology, Health Care and Pharmaceutical. Its work centres on Chronic Respiratory Diseases, Biomarker Tests, Healthcare Management and Real-time Assessment.
ProterixBio has completed 9 funding rounds, raising a total of $100.33M. The latest funding stage is Private Equity.
Top alternatives and competitors to ProterixBio include Tethys Bioscience, Inc., Aevice Health, Domus Diagnostics, Inc, HepQuant, LLC, NimBio. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
ProterixBio and Tethys Bioscience, Inc. are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for ProterixBio, https://bouncewatch.com/company/proterixbio, updated 27 December 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes